- 4 consecutive days & nights stay at our facility – you will be required to remain at our facility for this duration
- 4 quick follow-up appointments
About the study
For this clinical study, we require healthy people, who do not have any medical conditions. All participants are reimbursed for their time and this study is approved by an independent ethics committee.
This study is investigating a potential new treatment for diseases such as stroke, deep vein thrombosis, heart attacks, and embolism. Current anticoagulant medications reduce the occurrence of these diseases but carry with them an increased risk of bleeding. This study is investigating an anticoagulant with the potential for reduced bleeding risk compared to other treatment options.
We require healthy people who do not have any of the above mentioned medical conditions at this stage of the study. The data obtained will be used for further testing of the medication and will help determine whether the medication is approved for patient use.
How do I find out more?
Contact us on 1800 243 733 and quote “Flow Study” to find out the reimbursement amount and for more information.
If you are not already registered with us, please fill in your details below.